Welcome to our dedicated page for Inverse VIX S/T Futs ETNs due Mar22,2045 SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) brings together U.S. regulatory documents in which this security is formally identified. In multiple Form 8-K current reports filed by JPMorgan Chase & Co., VYLD appears in the table of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934.
In those filings, the Title of each class is given as the Guarantee of Inverse VIX Short-Term Futures ETNs due March 22, 2045 of JPMorgan Chase Financial Company LLC, the Trading Symbol is listed as VYLD, and the Name of each exchange on which registered is NYSE Arca, Inc. The same tables also list JPMorgan Chase & Co. common stock, depositary shares representing interests in various preferred stock series, and other guaranteed notes and ETNs.
Through this page, users can access the underlying Form 8-K reports and related exhibits where VYLD is mentioned. These filings may cover topics such as earnings releases, changes to by-laws, or the closing of public offerings of other notes and subordinated debt, with VYLD included in the standardized disclosure of registered securities.
Stock Titan enhances these filings with AI-powered summaries that explain the main points of each document in plain language, while still preserving access to the full official text from EDGAR. Users can quickly see where VYLD appears in the filing, understand the context of the report, and navigate to other securities listed in the same disclosure table.
For deeper analysis, investors can review successive filings over time to confirm that VYLD remains listed as a registered security and to see how it is grouped with other instruments issued or guaranteed by JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC.
JPMorgan Chase & Co director reports deferred stock award
A director of JPMorgan Chase & Co deferred a portion of their quarterly board retainer into company equity. On 12/31/2025, the director acquired 112.6694 shares of JPMorgan Chase common stock at a price of $322.22 per share, recorded as an acquisition rather than an open-market purchase.
After this transaction, the director beneficially owned a total of 13,726.3592 shares of JPMorgan Chase common stock, held directly. The filing explains that the award represents a deferral of the quarterly retainer that will be payable in common stock following the director’s termination of service.
JPMorgan Chase & Co. director reports deferred stock retainer
A director of JPMorgan Chase & Co. reported a Form 4 transaction dated 12/31/2025 involving company common stock. The filing shows an acquisition coded as “A(1),” with the footnote explaining this represents a deferral of the director’s quarterly cash retainer, which will be paid in common stock after the director’s service ends.
Following this transaction, the director beneficially owns 12,292.522 shares of JPMorgan Chase common stock held directly and 45 shares held indirectly through a spouse. The transaction reflects compensation taken in equity rather than cash, increasing the director’s reported ownership stake in the company.
JPMorgan Chase & Co. director activity shows a routine change in stock-based compensation. On 12/31/2025, a director acquired 139.6561 shares of common stock at
JPMorgan Chase & Co. director reports deferred stock compensation. A company director filed a report of a transaction dated 12/31/2025 showing acquisition of 174.5702 shares of JPMorgan Chase & Co. common stock at a price of $322.22 per share. The filing explains this represents a deferral of the director’s quarterly retainer, which will be paid in common stock following termination of service as a director.
After this transaction, the director beneficially owns 205,550.3435 shares directly and 55,245 shares indirectly through a Grantor Retained Annuity Trust. The filing notes that 19,755 shares were previously transferred from the trust to the grantor on 10/15/2025 under the trust’s terms, in a transaction described as exempt from Section 16 pursuant to Rule 16a-13.
JPMorgan Chase & Co. filed a Form 4 insider report for director Todd A. Combs. The filing indicates it is being submitted by one reporting person in his capacity as a director of JPMorgan Chase & Co. The document lists an earliest transaction date of 12/07/2025, but the provided tables do not show specific non-derivative or derivative security transaction details or holdings in this excerpt.
JPMorgan Chase & Co. reported that Todd A. Combs has resigned from its Board of Directors, effective December 7, 2025. The company states that Mr. Combs’ resignation is not the result of any disagreement with JPMorgan Chase on any matter relating to its operations, policies, or practices. The filing also reiterates the company’s listed securities, including its common stock, multiple series of preferred stock depositary shares, and certain guaranteed notes and exchange-traded notes.
JPMorgan Chase & Co. (JPM) reported an insider transaction by a senior officer. On 11/12/2025, the Co‑CEO of CIB filed a Form 4 showing a bona fide gift of 9,500 shares of common stock (Transaction Code G) at $0.0000. After the transaction, the reporting person beneficially owned 141,626 shares directly, plus 91.4063 shares held indirectly via a 401(k).
JPMorgan Chase & Co. (JPM) insider transaction: The company’s Head of Human Resources reported a sale of common stock on 11/07/2025. The filing shows a sale (code S) of 966 shares at a price of $311.9162 per share.
Following this transaction, the reporting person holds 58,479 JPM shares directly. The filing also lists indirect holdings of 9,333 shares by a GRAT and 9,333 shares by the spouse’s GRAT. This is a personal share transaction and does not involve the company receiving proceeds.
JPMorgan Chase (JPM): Notice of proposed sale under Rule 144. A stockholder filed a Form 144 indicating an intent to sell 966 shares of Common Stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $301,311.06. The approximate sale date is 11/07/2025.
The shares were acquired on 01/13/2025 as equity compensation awards granted by the issuer. Shares outstanding were 2,722,262,295. Form 144 is a notice of a planned sale and does not itself execute the transaction.
JPMorgan Chase & Co. filed a Form 13F Holdings Report, detailing institutional equity holdings for the quarter. The filing lists a Form 13F Information Table Entry Total of 32,847 positions and a Form 13F Information Table Value Total of $1,669,071,139,042. The report includes 17 Other Included Managers across its investment platform. The report is signed by Michael T. Lees, Executive Director.